Drawing for GLUCOBEAM

USPTO serial 79190266

GLUCOBEAM

Reviewed by CopyMark Law Group

Reg. 5225315Status 707Renewal
Filing date
Status date
Registration date
Jun 20, 2017
Examiner
PAQUIN, SAMUEL ROBERT
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with GLUCOBEAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew Fredbeck

Andrew Fredbeck Fross Zelnick Lehrman & Zissu, P.C.151 W 42nd Street, 17th Fl.New York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009[ Scientific microscopes, nautical compasses, surveying instruments, photographic cameras, cinematographic cameras, optical cables, weighing scales, measuring cups, signaling whistles, apparatus for checking flight parameters, life-saving rafts and medical teaching mannequins; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, blank recording discs; CDs featuring music, DVDs featuring movies and blank digital storage media; mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment, computers; computer software for operating medical devices; fire-extinguishing apparatus; computer programmes for data processing; computer operating system software; data communication software; computer software platforms for operating medical devices; downloadable electronic databases in the field of medical treatment; database management computer software; application software for operating medical devices; computer software applications for operating medical devices; scientific apparatus for measuring diabetes; computer application software for administration of diabetes; computer application software to create and maintain electronic logbooks; computer software for use with blood glucose measuring meters; software and software applications for mobile telephones, smartphones, tablets and other mobile devices and hand-held computers for operating medical devices; data processing apparatus for measuring, transmitting and receiving diabetes-related information and healthrelated information via mobile telephones, global computer networks and radio frequency technologies, namely, pagers, telephones, wireless data networks, messaging devices, personal digital assistants and satellite communications equipment; data processing systems for transmitting and receiving diabetes-related information to and from a central database, said system consisting of a glucose monitor, computer software and hardware and equipment based on radio frequency technology, namely, mobile telephones, pagers, telephones, wireless data networks, messaging devices, personal digital assistants and satellite communications equipment ]SECTION 71 - CANCELLED—
010[ surgical apparatus and instruments for medical use; artificial limbs, eyes and teeth; orthopedic appliances; suture materials; equipment, apparatus, instruments and measuring equipment for medical and diagnostic purposes, in particular for use in relation to the treatment of diabetes, and medical apparatus for measuring and displaying measurement data for body fluids, in particular of glucose, lactate, urea and cholesterol, and fittings therefor, included in this class, in particular blood glucose monitors; non-invasive medical apparatus and instruments for medical and diagnostic purposes, in particular for use in relation to the treatment of diabetes; device for measuring blood sugar ]ACTIVE—
035[ advertising; business management; business administration; office functions; database management services including compilation of customer-specific data and information, systemisation and storage of said information in written form and in pictorial form and in databases, processing of said information and providing of the results of said information processing; computerised file management; conducting of trade fairs for industrial, commercial and advertising purposes, exhibitions for industrial, commercial and advertising purposes, advertising events; demonstration of goods and services on the internet; advertising agencies; public relations services; organisation and conducting of trade fairs, exhibitions and events for commercial and advertising purposes, including virtually on the internet; conducting of product and service presentations and promotions, including in virtual form on the internet; advertising services relating to pharmaceuticals for the treatment of diabetes; wholesale and retail store services, online wholesale and retail store and mail order services featuring scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking, supervision, life-saving and teaching apparatus and instruments, apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity, apparatus for recording, transmission or reproduction of sound or images, magnetic data carriers, recording discs, compact discs, DVDs and other digital recording media, mechanisms for coin-operated apparatus, cash registers, calculating machines, data processing equipment, computers, computer software, fire-extinguishing apparatus, computer programs for data processing, computer operating system software, computer software for data communication, computer software platforms, electronic databases, computer software for database management, application software, computer software applications, devices for measuring diabetes, computer application software for diabetes management, computer application software for creating and maintaining electronic log books, computer software for use together with apparatus for measuring blood glucose, software, and software applications for mobile telephones, smartphones, tablets and other mobile devices and hand-held computers, apparatus for measuring, transmitting and receiving diabetes-related information and health-related information via mobile telephones, global computer networks and radio frequency technologies, namely, pagers, telephones, wireless data networks, messaging devices, personal digital assistants and satellite communications, systems for transmitting and receiving diabetes-related information to and from a central database, said system consisting of a glucose monitor, computer software and hardware and equipment based on radio frequency technology, namely, mobile telephones, pagers, telephones, wireless data networks, messaging devices, personal digital assistants and satellite communications, surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth, orthopedic articles, suture materials, equipment, apparatus, instruments and measuring equipment for medical and diagnostic purposes, in particular for use in relation to the treatment of diabetes, or medical apparatus for measuring and displaying measurement data for body fluids, in particular of glucose, lactate, urea and cholesterol, and fittings therefor, included in this class, in particular blood glucose monitors, noninvasive medical apparatus and instruments for medical and diagnostic purposes, in particular for use in relation to the treatment of diabetes ]SECTION 71 - CANCELLED—
038[ Telecommunications, in particular providing of access to internet platforms; transmission of information via the internet; providing of access to files via the internet; transmission of information via online access to databases; database services, namely, providing access to computer databases ]SECTION 71 - CANCELLED—
042Scientific and technological services, namely, research and design in the field of diabetes; [ industrial fluid analysis and medical research services; design and development of computer hardware and software; maintenance of software; updating of computer software for diagnostic service of clinical results in relation to diabetes; computer programming; ] providing an online searchable database, namely, providing scientific information about diabetes for others via computer and communication networks; [ design and development of databases; application service provider (ASP), namely, hosting computer software applications of others; development of software solutions for smartphones and smart devices; computer software design; computer software research; rental of software applications; ] scientific and technological services, namely, analysis and testing in the field of diabetes; [ development of medical software solutions for smartphones and smart-devices; ] development and implementation of smartphone software solution for diabetes management; [ writing of computer programs for medical applications; design and development of computer software and computer databases in the pharmaceutical and medical field; providing on-line non-downloadable software for use in reporting and analyzing the measurement and monitoring of glucose in diabetes patients; providing on-line, non-downloadable, internet-based software application for use in reporting and analyzing the measurement and monitoring of glucose in diabetes patients; industrial fluid analysis and medical research services in the field of diabetes; scientific research project management; scientific project management for the conducting of clinical trials; ] providing computerized scientific information in the field of scientific analysis, treatment, education and research; [ scientific research services about people affected by diabetes in developing countries; ] clinical research in the field of diabetes; [ consultancy services relating to the scientific evaluation of drugs and compounds having diagnostic properties; ] information, namely, online nondownloadable databases in the field of medical research services, clinical research data, and clinical trials in relation to diabetes management; [ medical and scientific research, namely, conducting clinical trials and studies for pharmaceutical preparations related to the treatment of diabetes-related diseases and disorders and providing scientific information on the efficacy of pharmaceutical preparations for the treatment of diabetes-related diseases and disorders ; ] scientific and medical research services in the field of diabetes [ ; consultancy services relating to the medical evaluation of drugs and compounds having diagnostic properties; updating of computer software applications for diagnostic service of clinical results in relation to diabetes ]ACTIVE—
044Medical services; medical services provided in relation to conducting of clinical trials; providing computerized information relating to medical analysis and medical treatment; non-downloadable database services, namely, providing medical information about diabetes for others via computer and communication networks [ ; medical services and pharmaceutical consultancy services; veterinary services; hygienic and beauty care for human beings or animals ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 20, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 11, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 27, 2025INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 2, 2025INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 2, 2025INPCINVALIDATION PROCESSED—
May 12, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 11, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 11, 202471.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Sep 10, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 19, 2023ES71TEAS SECTION 71 RECEIVED—
Feb 27, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 28, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 27, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 27, 2017FIMPFINAL DISPOSITION PROCESSED—
Sep 20, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 20, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2017GPNXNOTIFICATION PROCESSED BY IB—
Mar 15, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 15, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 15, 2017NPUBNOTICE OF PUBLICATION—
Feb 24, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 21, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 21, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 21, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2016RFNPREFUSAL PROCESSED BY IB—
Aug 26, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 26, 2016RFRRREFUSAL PROCESSED BY MPU—
Aug 26, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 25, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 19, 2016DOCKASSIGNED TO EXAMINER—
Aug 19, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 18, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance